Global and United States IPV Vaccine Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 IPV Vaccine Product Introduction
• 1.2 Global IPV Vaccine Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global IPV Vaccine Sales in US$ Million for the Year 2017-2028
  • 1.2.2 Global IPV Vaccine Sales in Volume for the Year 2017-2028
• 1.3 United States IPV Vaccine Outlook 2017 VS 2022 VS 2028
  • 1.3.1 United States IPV Vaccine Sales in US$ Million for the Year 2017-2028
  • 1.3.2 United States IPV Vaccine Sales in Volume for the Year 2017-2028
• 1.4 IPV Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4.1 The Market Share of United States IPV Vaccine in Global, 2017 VS 2022 VS 2028
  • 1.4.2 The Growth Rate of IPV Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.5 IPV Vaccine Market Dynamics
  • 1.5.1 IPV Vaccine Industry Trends
  • 1.5.2 IPV Vaccine Market Drivers
  • 1.5.3 IPV Vaccine Market Challenges
  • 1.5.4 IPV Vaccine Market Restraints
• 1.6 Study Objectives
• 1.7 Years Considered

2 Market by Type

• 2.1 IPV Vaccine Market Segment by Type
  • 2.1.1 Mahoney
  • 2.1.2 MEF1
  • 2.1.3 Saukett
• 2.2 Global IPV Vaccine Market Size by Type
  • 2.2.1 Global IPV Vaccine Sales in Value, by Type (2017, 2022 & 2028)
  • 2.2.2 Global IPV Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.2.3 Global IPV Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
• 2.3 United States IPV Vaccine Market Size by Type
  • 2.3.1 United States IPV Vaccine Sales in Value, by Type (2017, 2022 & 2028)
  • 2.3.2 United States IPV Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.3.3 United States IPV Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 IPV Vaccine Market Segment by Application
  • 3.1.1 Private Distribution Channel
  • 3.1.2 Public Distribution Channel
• 3.2 Global IPV Vaccine Market Size by Application
  • 3.2.1 Global IPV Vaccine Sales in Value, by Application (2017, 2022 & 2028)
  • 3.2.2 Global IPV Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 Global IPV Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
• 3.3 United States IPV Vaccine Market Size by Application
  • 3.3.1 United States IPV Vaccine Sales in Value, by Application (2017, 2022 & 2028)
  • 3.3.2 United States IPV Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 United States IPV Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global IPV Vaccine Competitor Landscape by Company

• 4.1 Global IPV Vaccine Market Size by Company
  • 4.1.1 Top Global IPV Vaccine Manufacturers Ranked by Revenue (2021)
  • 4.1.2 Global IPV Vaccine Revenue by Manufacturer (2017-2022)
  • 4.1.3 Global IPV Vaccine Sales by Manufacturer (2017-2022)
  • 4.1.4 Global IPV Vaccine Price by Manufacturer (2017-2022)
• 4.2 Global IPV Vaccine Concentration Ratio (CR)
  • 4.2.1 IPV Vaccine Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of IPV Vaccine in 2021
  • 4.2.3 Global IPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global IPV Vaccine Manufacturing Base Distribution, Product Type
  • 4.3.1 Global IPV Vaccine Manufacturers, Headquarters and Distribution of Producing Region
  • 4.3.2 Manufacturers IPV Vaccine Product Type
  • 4.3.3 Date of International Manufacturers Enter into IPV Vaccine Market
• 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
• 4.5 United States IPV Vaccine Market Size by Company
  • 4.5.1 Top IPV Vaccine Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States IPV Vaccine Revenue by Players (2020, 2021 & 2022)
  • 4.5.3 United States IPV Vaccine Sales by Players (2020, 2021 & 2022)

5 Global IPV Vaccine Market Size by Region

• 5.1 Global IPV Vaccine Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global IPV Vaccine Market Size in Volume by Region (2017-2028)
  • 5.2.1 Global IPV Vaccine Sales in Volume by Region: 2017-2022
  • 5.2.2 Global IPV Vaccine Sales in Volume Forecast by Region (2023-2028)
• 5.3 Global IPV Vaccine Market Size in Value by Region (2017-2028)
  • 5.3.1 Global IPV Vaccine Sales in Value by Region: 2017-2022
  • 5.3.2 Global IPV Vaccine Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America IPV Vaccine Market Size YoY Growth 2017-2028
  • 6.1.2 North America IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific IPV Vaccine Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific IPV Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe IPV Vaccine Market Size YoY Growth 2017-2028
  • 6.3.2 Europe IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America IPV Vaccine Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
  • 6.4.6 Colombia
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa IPV Vaccine Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 GlaxoSmithKline Plc
  • 7.1.1 GlaxoSmithKline Plc Corporation Information
  • 7.1.2 GlaxoSmithKline Plc Description and Business Overview
  • 7.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.1.4 GlaxoSmithKline Plc IPV Vaccine Products Offered
  • 7.1.5 GlaxoSmithKline Plc Recent Development
• 7.2 Sanofi S.A
  • 7.2.1 Sanofi S.A Corporation Information
  • 7.2.2 Sanofi S.A Description and Business Overview
  • 7.2.3 Sanofi S.A IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.2.4 Sanofi S.A IPV Vaccine Products Offered
  • 7.2.5 Sanofi S.A Recent Development
• 7.3 Serum Institute of India Pvt. Ltd.
  • 7.3.1 Serum Institute of India Pvt. Ltd. Corporation Information
  • 7.3.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
  • 7.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Products Offered
  • 7.3.5 Serum Institute of India Pvt. Ltd. Recent Development
• 7.4 PT Bio Farma
  • 7.4.1 PT Bio Farma Corporation Information
  • 7.4.2 PT Bio Farma Description and Business Overview
  • 7.4.3 PT Bio Farma IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.4.4 PT Bio Farma IPV Vaccine Products Offered
  • 7.4.5 PT Bio Farma Recent Development
• 7.5 AJ Vaccines
  • 7.5.1 AJ Vaccines Corporation Information
  • 7.5.2 AJ Vaccines Description and Business Overview
  • 7.5.3 AJ Vaccines IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 7.5.4 AJ Vaccines IPV Vaccine Products Offered
  • 7.5.5 AJ Vaccines Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 IPV Vaccine Industry Chain Analysis
• 8.2 IPV Vaccine Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 IPV Vaccine Distributors
• 8.3 IPV Vaccine Production Mode & Process
• 8.4 IPV Vaccine Sales and Marketing
  • 8.4.1 IPV Vaccine Sales Channels
  • 8.4.2 IPV Vaccine Distributors
• 8.5 IPV Vaccine Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details